Attempts to devise a vaccine against syphilis have been pursued for decades but thus far with little success. For the most part investigations have been focused on Treponema pallidum, modified in various ways, on the Reiter treponeme and its protein fractions, and on the closely related Borrelia organism.
Inoculation with Treponema pallidum produces a degree ofimmunity to re-infection and Neisser (1911) and others suggested that this immunity persisted as long as the original infection was maintained. Chesney (1926) postulated that resistance to reinfection was proportional to the duration of the original disease; even after treatment the immunity would still persist so long as the duration of the original infection, before treatment, had been sufficient. Magnuson, Thomas, Olansky, Kaplan, *Received for publication June 26, 1968. de Mello, and Cutler (1956) (1933) re- ported that when forty neuro-syphilitics were inoculated with yaws treponemes only one became infected. Akrawi (1949) reported that eight patients with late syphilis were challenged with bejel treponemes and no infections resulted. As controls he used ten volunteers with no history of syphilis and repeated negative results to serum tests; when they were inoculated with bejel treponemes eight of them became sero-positive, producing erosive lesions at the site of the inoculation. In the same study Akrawi attempted to superinfect two bejel patients with bejel treponemes, and both attempts failed. As previously stated, Magnuson and others (1956) reported that five patients with latent syphilis were challenged with syphilis treponemes but no re-infections resulted.
From these studies it is clear that infection with one of the above-mentioned treponemes does provide a degree of immunity to infection with some or all of the other treponemes. The least pathogenic of the treponemes is Treponema carateum, which causes only lesions of the skin. It is suggested that with the pinta treponeme, much of the work of attenuating Treponema pallidum as a step in the elaboration of a vaccine, has already been done. 
